Working together and apart: The twisted relationship of the Mre11 complex and Chk2 in apoptosis and tumor suppression

Cell Cycle

Volumn 7, Issue 23, 2008, Pages 3618-3621

  Stracker, Travis H ^a   Petrini, John H J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

Apoptosis; Brca1; Cancer; Chk2; Mre11; Nbs1; Rad50

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; DEOXYRIBONUCLEOPROTEIN; PROTEIN P53; PROTIEN MRE11; UNCLASSIFIED DRUG;

APOPTOSIS; B CELL LYMPHOMA; CANCER INHIBITION; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; HUMAN; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PROTEIN INTERACTION; REVIEW; T CELL LYMPHOMA;

ATAXIA TELANGIECTASIA; MURINAE;

EID: 57349181439     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.23.7064     Document Type: Review

References (27)

1. Stracker TH, Theunissen JW, Morales M, Petrini JH. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair (Amst) 2004; 3:845-54.
2. Williams BR, Mirzoeva OK, Morgan WF, Lin J, Dunnick W, Petrini JH. A murine model of nijmegen breakage syndrome. Curr Biol 2002; 12:648-53.
3. Theunissen JW, Kaplan MI, Hunt PA, Williams BR, Ferguson DO, Alt FW, Petrini JH. Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice. Mol Cell 2003; 12:1511-23.
4. Stracker TH, Morales M, Couto SS, Hussein H, Petrini JH. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 2007; 447:218-21
5. Stracker TH, Couto SS, Cordon-Cardo C, Matos T, Petrini JH. Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. Mol Cell 2008; 31:21-32.
6. Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007; 26:7773-9.
7. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 2002; 21:5195-205.
8. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 2002; 22:6521-32.
9. Petrini JH, Stracker TH. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol 2003; 13:458-62.
10. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007; 26:7741-8.
11. Ahn J, Urist M, Prives C. The Chk2 protein kinase. DNA Repair (Amst) 2004; 3:1039-47.
12. Oliver AW, Knapp S, Pearl LH. Activation segment exchange: a common mechanism of kinase autophosphorylation? Trends Biochem Sci 2007; 32:351-6.
13. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499-506.
14. Difilippantonio S, Celeste A, Kruhlak MJ, Lee Y, Difilippantonio MJ, Feigenbaum L, et al. Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J Exp Med 2007; 204:1003-11.
15. Li J, Stern DF. Regulation of CHK2 by DNA-dependent protein kinase. J Biol Chem 2005; 280:12041-50.
16. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 2000; 97:10389-94.
17. Attardi LD, Jacks T. The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 1999; 55:48-63.
18. Petrini JH, Theunissen JW. Double strand break metabolism and cancer susceptibility: Lessons from the Mre11 complex. Cell Cycle 2004; 3.
19. Paulovich AG, Hartwell LH. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 1995; 82:841-7.
20. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra - S phase checkpoint is regulated by parallel pathways. Nat Genet 2002; 30:290-4.
21. Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M. V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 1992; 70:983-91.
22. Bassing CH, Alt FW. The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst) 2004; 3:781-96.
23. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF, Danska JS. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocytes. Genes & Dev 1996; 10:2038-54.
24. Nacht M, Strasser A, Chan YR, Harris AW, Schlissel S, Bronson RT, Jacks T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes & Dev 1996; 10:2055-66.
25. McPherson JP, Lemmers B, Hirao A, Hakem A, Abraham J, Migon E, et al. Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev 2004; 18:1144-53.
26. Cao L, Kim S, Xiao C, Wang RH, Coumoul X, Wang X, et al. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J 2006; 25:2167-77.
27. Barboza JA, Liu G, Ju Z, El-Naggar AK, Lozano G. p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci USA 2006; 103:19842-7.